Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
He has published more than 100 research papers in several prestigious national and international journals
Subscribe To Our Newsletter & Stay Updated
